XML 249 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Changes in Shareholders Equity - USD ($)
$ in Thousands
Total
Advisors
LI Lending LLC
Cannex Capital Holdings Inc
Class F Units
Class F Units
PHX Interactive LLC
Class F Units
Om of Medicine LLC
Share Capital
Share Capital
Cannex Capital Holdings Inc
Share Capital
Class F Units
Share Capital
Class F Units
PHX Interactive LLC
Share Capital
Class F Units
Om of Medicine LLC
Share Capital
Class F Units
Cannex Capital Holdings Inc
Additional Paid-In Capital
Additional Paid-In Capital
Advisors
Additional Paid-In Capital
LI Lending LLC
Additional Paid-In Capital
Cannex Capital Holdings Inc
Deficit
Total 4Front Ventures Corp. Shareholders' Equity
Total 4Front Ventures Corp. Shareholders' Equity
Advisors
Total 4Front Ventures Corp. Shareholders' Equity
LI Lending LLC
Total 4Front Ventures Corp. Shareholders' Equity
Cannex Capital Holdings Inc
Total 4Front Ventures Corp. Shareholders' Equity
Class F Units
Total 4Front Ventures Corp. Shareholders' Equity
Class F Units
PHX Interactive LLC
Total 4Front Ventures Corp. Shareholders' Equity
Class F Units
Om of Medicine LLC
Noncontrolling Interest
Beginning Balance at Dec. 31, 2018 $ 48,031             $ 68,959           $ 2,227       $ (21,487) $ 49,699             $ (1,668)
Beginning balance, Number of units at Dec. 31, 2018               803,591                                    
Class F Units of Holdings for Acquisition       $ 187,935   $ 2,676 $ 4,400   $ 181,110   $ 2,676 $ 4,400         $ 6,825         $ 187,935   $ 2,676 $ 4,400  
Class F Units of Holdings for Acquisition, Units                 190,482,146   5,496 9,040 3,901                          
Class F Units of Holdings for acquisition of non-controlling interests         $ 7,989         $ 7,989                         $ 7,989      
Class F Units of Holdings for acquisition of non-controlling interests, units                   11,642                                
Purchase of non-controlling interests (8,390)             $ (10,156)                     (10,156)             1,766
Issuance of Class F units to brokers         $ 115         $ 115                         $ 115      
Insuance of Class F units to brokers, units                   236                                
Share issuance costs (115)             $ (115)                     (115)              
Share-based compensation through July 31, 2019 3,776                         3,776         3,776              
Share-based compensation through July 31, 2019, units               34,572                                    
Conversion of 4Front Holdings units to 4Front Ventures Corp, units               (868,478)                                    
Conversion of 4Front Holdings units to 4Front Ventures Corp, shares               340,370,271                                    
GGP warrants acquired with Cannex 5,779                         5,779         5,779              
Issuance of broker warrants 1,823                         1,823         1,823              
Share issuance costs (1,823)                         (1,823)         (1,823)              
Issuance of shares to brokers 420             $ 420                     420              
Issuance of shares to brokers, shares               1,035,456                                    
Share issuance costs (420)             $ (420)                     (420)              
Conversion option on GGP notes transferred to equity 4,874                         4,874         4,874              
Purchase of non-controlling interests in Arkansas entities (2,322)             $ (2,322)                     (2,322)              
Share-based compensation after July 31, 2019 2,137                         2,137         2,137              
Return of treasury shares               (365,054)                                    
Net loss (182,125)                                 (182,010) (182,010)             (115)
Ending Balance at Dec. 31, 2019 74,760             $ 252,656           25,618       (203,497) 74,777             (17)
Ending Balance, Shares at Dec. 31, 2019               531,522,819                                    
Conversion option and warrants with notes transferred to equity 411                         411         411              
Conversion option for convertible notes transferred to equity 5,163                         5,163         5,163              
Shares issued for Pure Ratios earnout 94             $ 94                     94              
Shares issued for Pure Ratios earnout, shares               223,145                                    
Share-based compensation 5,306                         5,306         5,306              
Exchange of stock for convertible swap notes (13,661)             $ (13,661)                     (13,661)              
Exchange of stock for convertible swap notes, shares               (29,448,468)                                    
Conversion of notes to equity 1,939             $ 1,939                     1,939              
Conversion of notes to equity, shares               4,479,113                                    
Shares issued with exercise of warrants 1,352             $ 1,352                     1,352              
Shares issued with exercise of warrants, shares               2,686,463                                    
Shares issued for services 644             $ 644                     644              
Shares issued for services, shares               1,192,640                                    
Issuance of stock for purchase of non-controlling interests               $ 231                     231             (231)
Issuance of stock for purchase of non-controlling interests, shares               3,551,040                                    
Derecognition of NCI with the sale of Maryland entities 254                                                 254
Issuance of stock for bought deal 8,018             $ 8,018                     8,018              
Issuance of stock for bought deal, shares               24,644,500                                    
Share issuance costs for bought deal (690)             $ (690)                     (690)              
Issuance of warrants   $ 381 $ 4,660                       $ 381 $ 4,660       $ 381 $ 4,660          
Issuance of broker warrants 577                         577         577              
Net loss (47,005)                                 (47,051) (47,051)             46
Ending Balance at Dec. 31, 2020 $ 42,203             $ 250,583           $ 42,116       $ (250,548) $ 42,151             $ 52
Ending Balance, Shares at Dec. 31, 2020 538,851,252             538,851,252